1
|
Rotzetter ACC, Schumacher CM, Zako T, Stark WJ, Maeda M. Rapid surface-biostructure interaction analysis using strong metal-based nanomagnets. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2013; 29:14117-14123. [PMID: 24151962 DOI: 10.1021/la4026427] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Nanomaterials are increasingly suggested for the selective adsorption and extraction of complex compounds in biomedicine. Binding of the latter requires specific surface modifications of the nanostructures. However, even complicated macromolecules such as proteins can afford affinities toward basic surface characteristics such as hydrophobicity, topology, and electrostatic charge. In this study, we address these more basic physical interactions. In a model system, the interaction of bovine serum albumin and amyloid β 42 fibrillar aggregates with carbon-coated cobalt nanoparticles, functionalized with various polymers differing in character, was studied. The possibility of rapid magnetic separation upon binding to the surface represents a valuable tool for studying surface interactions and selectivities. We find that the surface interaction of Aβ 42 fibrillar aggregates is mostly hydrophobic in nature. Because bovine serum albumin (BSA) is conformationally adaptive, it is known to bind surfaces with widely differing properties (charge, topology, and hydrophobicity). However, the rate of tight binding (no desorption upon washing) can vary largely depending on the extent of necessary conformational changes for a specific surface. We found that BSA can only bind slowly to polyethylenimine-coated nanomagnets. Under competitive conditions (high excess BSA compared to that for β 42 fibrillar aggregates), this effect is beneficial for targeting the fibrillar species. These findings highlight the possibility of selective extractions from complex media when advantageous basic physical surface properties are chosen.
Collapse
Affiliation(s)
- Aline C C Rotzetter
- ETH Zurich, Institute for Chemical and Bioengineering , Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland
| | | | | | | | | |
Collapse
|
2
|
Buell AK, Esbjörner EK, Riss PJ, White DA, Aigbirhio FI, Toth G, Welland ME, Dobson CM, Knowles TPJ. Probing small molecule binding to amyloid fibrils. Phys Chem Chem Phys 2011; 13:20044-52. [PMID: 22006124 DOI: 10.1039/c1cp22283j] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Much effort has focussed in recent years on probing the interactions of small molecules with amyloid fibrils and other protein aggregates. Understanding and control of such interactions are important for the development of diagnostic and therapeutic strategies in situations where protein aggregation is associated with disease. In this perspective article we give an overview over the toolbox of biophysical methods for the study of such amyloid-small molecule interactions. We discuss in detail two recently developed techniques within this framework: linear dichroism, a promising extension of the more traditional spectroscopic techniques, and biosensing methods, where surface-bound amyloid fibrils are exposed to solutions of small molecules. Both techniques rely on the measurement of physical properties that are very directly linked to the binding of small molecules to amyloid aggregates and therefore provide an attractive route to probe these important interactions.
Collapse
Affiliation(s)
- Alexander K Buell
- Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Sipos E, Kurunczi A, Fehér A, Penke Z, Fülöp L, Kasza Á, Horváth J, Horvát S, Veszelka S, Balogh G, Kürti L, Erős I, Szabó-Révész P, Párducz Á, Penke B, Deli MA. Intranasal delivery of human beta-amyloid peptide in rats: effective brain targeting. Cell Mol Neurobiol 2010; 30:405-13. [PMID: 19806448 PMCID: PMC11498860 DOI: 10.1007/s10571-009-9463-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2009] [Accepted: 09/17/2009] [Indexed: 12/20/2022]
Abstract
(1) Intranasal administration is a non-invasive and effective way for the delivery of drugs to brain that circumvents the blood-brain barrier. The aims of the study were to test a nasal delivery system for human beta-amyloid (A beta) peptides, to measure the delivery of the peptides to brain regions, and to test their biological activity in rats. (2) A beta(1-42), in the form of a mixture of oligomers, protofibrils, and fibrils was dissolved in a nasal formulation containing hydrophobic, hydrophylic, and mucoadhesive components. The peptide solution was administered intranasally to rats as a single dose or in repeated doses. (3) Nasally injected A beta labeled with the blue fluorescent dye amino-methyl coumarinyl acetic acid (AMCA) could be detected by fluorescent microscopy in the olfactory bulb and frontal cortex. The concentration of the peptide was quantified by fluorescent spectroscopy, and a significant amount of AMCA-A beta peptide could be detected in the olfactory bulb. Unlabeled A beta also reached the olfactory bulb and frontal cortex of rats as evidenced by intense immunostaining. (4) In behavioral experiments, nasal A beta treatment did not affect anxiety levels (open-field test) and short-term memory (Y-maze test), but significantly impaired long-term spatial memory in the Morris water maze. The treatments did not result in A beta immunization. (5) The tested intranasal delivery system could successfully target a bioactive peptide into the central nervous system and provides a basis for developing a non-invasive and cost effective, new model to study amyloid-induced dysfunctions in the brain.
Collapse
Affiliation(s)
- Eszter Sipos
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
| | - Anita Kurunczi
- Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Temesvári krt. 62., 6726 Szeged, Hungary
| | - András Fehér
- Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
| | - Zsuzsa Penke
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
| | - Lívia Fülöp
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
| | - Ágnes Kasza
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
| | - János Horváth
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
| | - Sándor Horvát
- Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Temesvári krt. 62., 6726 Szeged, Hungary
- Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
| | - Szilvia Veszelka
- Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Temesvári krt. 62., 6726 Szeged, Hungary
| | - Gábor Balogh
- Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary
| | - Levente Kürti
- Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
| | - István Erős
- Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
| | | | - Árpád Párducz
- Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Temesvári krt. 62., 6726 Szeged, Hungary
| | - Botond Penke
- Department of Medical Chemistry, University of Szeged, Szeged, Hungary
- Supramolecular and Nanostructured Materials Research Group, Hungarian Academy of Science, Szeged, Hungary
| | - Mária A. Deli
- Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Temesvári krt. 62., 6726 Szeged, Hungary
| |
Collapse
|
4
|
Linser R, Fink U, Reif B. Probing Surface Accessibility of Proteins Using Paramagnetic Relaxation in Solid-State NMR Spectroscopy. J Am Chem Soc 2009; 131:13703-8. [DOI: 10.1021/ja903892j] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Rasmus Linser
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, D-13125 Berlin, Germany and Charité Universitätsmedizin, D-10115 Berlin, Germany
| | - Uwe Fink
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, D-13125 Berlin, Germany and Charité Universitätsmedizin, D-10115 Berlin, Germany
| | - Bernd Reif
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Str. 10, D-13125 Berlin, Germany and Charité Universitätsmedizin, D-10115 Berlin, Germany
| |
Collapse
|